These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15350159)

  • 1. Targeting tachykinins for the treatment of obstructive airways disease.
    Mazzone SB
    Treat Respir Med; 2004; 3(4):201-16. PubMed ID: 15350159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway inflammation and tachykinins: prospects for the development of tachykinin receptor antagonists.
    Joos GF; De Swert KO; Pauwels RA
    Eur J Pharmacol; 2001 Oct; 429(1-3):239-50. PubMed ID: 11698044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of tachykinins in sephadex-induced airway hyperreactivity and inflammation in guinea pigs.
    Tramontana M; Santicioli P; Giuliani S; Catalioto RM; Lecci A; Carini F; Maggi CA
    Eur J Pharmacol; 2002 Mar; 439(1-3):149-58. PubMed ID: 11937105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extending the understanding of sensory neuropeptides.
    De Swert KO; Joos GF
    Eur J Pharmacol; 2006 Mar; 533(1-3):171-81. PubMed ID: 16464447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tachykinins, sensory nerves, and asthma--an overview.
    Lundberg JM
    Can J Physiol Pharmacol; 1995 Jul; 73(7):908-14. PubMed ID: 8846429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of tachykinins in bronchial hyper-responsiveness.
    Reynolds PN; Holmes MD; Scicchitano R
    Clin Exp Pharmacol Physiol; 1997; 24(3-4):273-80. PubMed ID: 9131297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tachykinin receptor antagonists: potential in airways diseases.
    Joos GF; Pauwels RA
    Curr Opin Pharmacol; 2001 Jun; 1(3):235-41. PubMed ID: 11712745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tachykinin receptor antagonists in the prevention of bronchial hyperresponsiveness, airway inflammation and cough.
    Advenier C; Lagente V; Boichot E
    Eur Respir J; 1997 Aug; 10(8):1892-906. PubMed ID: 9272936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tachykinin antagonists and the airways.
    Joos GF; Kips JC; Peleman RA; Pauwels RA
    Arch Int Pharmacodyn Ther; 1995; 329(1):205-19. PubMed ID: 7543746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-inflammatory effects of substance P: new perspectives for the treatment of airway diseases?
    Joos GF; Pauwels RA
    Trends Pharmacol Sci; 2000 Apr; 21(4):131-3. PubMed ID: 10740286
    [No Abstract]   [Full Text] [Related]  

  • 11. Peripheral tachykinin receptors as targets for new drugs.
    Patacchini R; Maggi CA
    Eur J Pharmacol; 2001 Oct; 429(1-3):13-21. PubMed ID: 11698023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensory neuropeptides and the human lower airways: present state and future directions.
    Joos GF; Germonpre PR; Kips JC; Peleman RA; Pauwels RA
    Eur Respir J; 1994 Jun; 7(6):1161-71. PubMed ID: 7925887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs.
    Longmore J; Hill RG; Hargreaves RJ
    Can J Physiol Pharmacol; 1997 Jun; 75(6):612-21. PubMed ID: 9276138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurokinin receptor antagonists.
    Leroy V; Mauser P; Gao Z; Peet NP
    Expert Opin Investig Drugs; 2000 Apr; 9(4):735-46. PubMed ID: 11060706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of tachykinins in asthma.
    Joos GF; Germonpré PR; Pauwels RA
    Allergy; 2000 Apr; 55(4):321-37. PubMed ID: 10782516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purines and sensory neuropeptides in human asthma.
    Karlsson JA
    Bull Eur Physiopathol Respir; 1987; 23 Suppl 10():95s-101s. PubMed ID: 2822185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tachykinin receptors antagonism for asthma: a systematic review.
    Ramalho R; Soares R; Couto N; Moreira A
    BMC Pulm Med; 2011 Aug; 11():41. PubMed ID: 21810226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of neural inflammation in asthma and chronic obstructive pulmonary disease.
    Joos GF; De Swert KO; Schelfhout V; Pauwels RA
    Ann N Y Acad Sci; 2003 May; 992():218-30. PubMed ID: 12794061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.
    Hirayama Y; Lei YH; Barnes PJ; Rogers DF
    Br J Pharmacol; 1993 Mar; 108(3):844-51. PubMed ID: 7682142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of the tachykinin NK(2) receptor antagonist MEN11420 (nepadutant) on neurokinin A-induced bronchoconstriction in asthmatics.
    Schelfhout V; Van De Velde V; Maggi C; Pauwels R; Joos G
    Ther Adv Respir Dis; 2009 Oct; 3(5):219-26. PubMed ID: 19880429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.